Moving along…slow but sure First, I'm away on a bit of a healing break.
internet is poor at best here.
Lots going on in the geopolitical & financial world.
Too much to mention.
Never in my 40+ years of being an investor have I ever appreciated having 98% of our $$ professionally managed.
Doing the math, ONC represents at most 1% of our investable assets.
i do hold a few other stocks. Total other end of spectrum.
Thst being solid, dividend paying profitable companies.
Why the preface?
As I have said many times over. I could care less about the day- day stock price off ONC.
i do care a lot about their potential.
why?
Looking at the fundamentals/ background.
onc has reached a crossroads.
perhaps, we have been here before? Is this time different?
Recent analysts have given 12 month price targets average $5ps ( usd).
None of the calculations include a complete buyout.
Why so long.., why not yet?
Actully there was a potential deal, Some time around 2017.
The word was, regardless of price, the aquiiring company would hav3 total control of Pelareoreps future.
Including shutting it down.
since then, the whole trial & evaluation of results have lead to intersting & very valuable conclusions.
1. Pela is best utilized as a co- therapy.
2. priming the imune system , can expand the patient base, of existing standard of care cancer treatments.
2. The pancreatic cancer treatment exceeded all expectations & granted FDA fast track approval. & The support of originally PanCan " precicion promise" , now CGAR
3. The pancreatic cancer phase 3 trial is expected to begin early 2025.
4. The long awaited MBc overall survival results are due before the end if this year.
5. While the panc cancer phase 3, seems to have direction, the MBc does not. Company's web site says regarding MBc ( TBD).....The recent public presentations discussed that. Simple language.
They need solid results to take to the table as part of negotiations to get the best deal possible.
stepping back from the details.
Should Pelareorep get approved for either pancreatic or MBc cancers. The upside is well beyond anyone's imagination.
Getting approval for both!, would move Onc into blockbuster status.
lots said.
My bottom line has not changed.
if they fail, my losses are minimal.
if they sucseed my potential gains are huge.
The $billion buy out opportunity is still very possible.
Next set if MBc O.S. Resukts and/ or the progress of pancreatic phase 3, will be a good start in that direction.
until then, lots of waiting.
Repeating the irony. The longer MBc O.S. Reults take the better.
the events they are talking about , are patents dieing.
Most people on this site , seem to be intelligent beings.
Prove that intelligence by keeping the discussions to ONC.
first read, this is called Stockhouse...aka stock markets etc
second read, this is Onc site,
Hoping for some Onc news soon.
all the best.